Sawai Group Holdings Co., Ltd.

OTCPK:SWGH.F Stock Report

Market Cap: US$1.8b

Sawai Group Holdings Past Earnings Performance

Past criteria checks 4/6

Sawai Group Holdings's earnings have been declining at an average annual rate of -17.4%, while the Pharmaceuticals industry saw earnings declining at 0.3% annually. Revenues have been growing at an average rate of 0.3% per year. Sawai Group Holdings's return on equity is 6.2%, and it has net margins of 10.6%.

Key information

-17.4%

Earnings growth rate

-17.4%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate0.3%
Return on equity6.2%
Net Margin10.6%
Next Earnings Update11 Nov 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sawai Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:SWGH.F Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24168,20117,75620,06411,746
31 Mar 24176,86217,21823,24412,189
31 Dec 23185,30917,70923,83612,885
30 Sep 23191,32414,54526,48114,460
30 Jun 23205,10212,51331,55615,688
31 Mar 23200,34412,66730,15616,090
31 Dec 22196,280-33,30731,58414,414
30 Sep 22192,928-31,03131,45814,767
30 Jun 22191,561-30,90431,71915,468
31 Mar 22193,816-28,26932,49916,456
31 Dec 21193,14910,83534,08216,952
30 Sep 21194,34910,96234,93715,367
30 Jun 21193,76313,17734,93314,697
31 Mar 21187,21912,34034,85113,397
31 Dec 20184,96819,34847,706-158
30 Sep 20182,22819,10747,214-203
30 Jun 20179,34518,31347,240-629
31 Mar 20182,53719,27933,88812,974
31 Dec 19186,61019,89127,82115,982
30 Sep 19186,03019,83127,31216,067
30 Jun 19186,17720,55426,89217,130
31 Mar 19184,34119,37632,38016,671
31 Dec 18189,52616,77721,60624,692
30 Sep 18186,10215,74326,10421,488
30 Jun 18179,72014,61928,06217,588
31 Mar 18168,06814,01728,48614,533
31 Dec 17147,59216,26828,18110,207
30 Sep 17137,77016,14023,22910,207
30 Jun 17133,12616,21321,10310,207
31 Mar 17132,42815,91420,45510,207
31 Dec 16132,49016,84021,7008,019
30 Sep 16129,95017,22221,3458,019
30 Jun 16127,05416,42120,8978,019
31 Mar 16123,49217,15519,6048,019
31 Dec 15117,64116,35320,6716,109
30 Sep 15114,21015,55419,6376,109
30 Jun 15109,71615,70618,3026,109
31 Mar 15105,45414,05317,9036,109
31 Dec 14102,08313,06418,5255,170
30 Sep 1497,27912,71317,9355,170
30 Jun 1493,04111,86017,6185,170
31 Mar 1489,82312,19216,5825,170
31 Dec 1387,42313,01716,2264,550
30 Sep 1384,80213,02615,8444,550

Quality Earnings: SWGH.F has high quality earnings.

Growing Profit Margin: SWGH.F's current net profit margins (10.6%) are higher than last year (6.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SWGH.F's earnings have declined by 17.4% per year over the past 5 years.

Accelerating Growth: SWGH.F's earnings growth over the past year (41.9%) exceeds its 5-year average (-17.4% per year).

Earnings vs Industry: SWGH.F earnings growth over the past year (41.9%) exceeded the Pharmaceuticals industry 13%.


Return on Equity

High ROE: SWGH.F's Return on Equity (6.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies